B. Wainwright

B. Wainwright is a researcher at the German Cancer Research Center (DKFZ) specializing in medulloblastoma and Sonic Hedgehog pathway research within the Department of Molecular Oncology. With publications spanning from 2014 to 2025, Wainwright has established themselves as a consistent contributor to the field of neuro-oncology.

Research interests focus on molecular mechanisms of medulloblastoma development, with particular emphasis on the Sonic Hedgehog signaling pathway, germline mutations in cancer predisposition, and identification of therapeutic targets. Key areas include tumor cell survival mechanisms, medulloblastoma subtypes, and the role of specific proteins like Netrin-1 and Neogenin1 in cancer progression.

Recent publications demonstrate a trajectory from fundamental molecular research toward translational applications, with involvement in studies examining potential therapeutic targets like MDM2 and clinical applications of pathway inhibitors. The research shows strong international collaboration patterns across multiple institutions.

While specific awards and mentoring activities aren't documented in the provided materials, the consistent publication record in high-impact journals (Nature, Cancer Cell, Nature Communications) indicates recognition within the neuro-oncology research community. Current work appears focused on developing targeted therapies for medulloblastoma subtypes with particular genetic profiles.